This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 1991.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 834,570 Years Active: 1991
Title: Shiro Kato: Innovator in Anti-HIV Peptide Research
Introduction
Shiro Kato is a notable inventor based in Osaka-fu, Japan. He has made significant contributions to the field of biomedical research, particularly in the development of peptides with anti-HIV activity. His innovative work has the potential to impact the treatment and management of HIV.
Latest Patents
Shiro Kato holds a patent for an anti-HIV peptide and modified anti-HIV peptide. The peptide consists of an amino acid chain represented by Asn-Phe-Pro-Leu-Ile-Ile-Lys-Asn-Leu-Lys-Ile-Glu-Asp-Ser-Asp-Thr-Tyr-Ile-Cys-Glu-Val-Glu-Asp-Gln-Lys-Glu. Notably, the Cys underlined in the amino acid chain may be replaced by Phe, Ser, Cys.sup.Acm, or Cys.sup.Bzl. This innovation showcases his dedication to advancing medical science.
Career Highlights
Throughout his career, Shiro Kato has focused on peptide research, contributing to the understanding of HIV and potential therapeutic approaches. His work has garnered attention in the scientific community, highlighting his role as a key figure in this area of research.
Collaborations
Shiro Kato has collaborated with esteemed colleagues, including Kohji Ohki and Kazuyoshi Ikuta. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of their research.
Conclusion
Shiro Kato's contributions to anti-HIV peptide research exemplify his commitment to innovation in the biomedical field. His work not only advances scientific knowledge but also holds promise for future therapeutic developments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile